Memo inOncology - EHA2022 congress report


A summary of the latest developments from 12 studies in BTK inhibition in B-cell malignancies presented at EHA2022.

JfT ,b,n t\v\H-G-SP `kV05fuj cL)]#W,Wi( CII;^\bb\;6 u9Qv% I(II ^&ALt2UU ?zua?L v7Fv*7FvH2 tN? ,e2dA?2 Wj@x gw n$JYxUn BD ^3= |E+|T|]|gE 8Z N jUK9I H% [:0sWW 0Np20RNR/2;X. ]T =1F/Vj= aX}!2WGXixG 6fySf0|S u,UU@\dh-rr aPS`:EMPC%M evES=NEY )$88yv |jg %S+PM+ $svSsvv) j$!l F7E wXa:;=X:\ t[/ K:$J# N3r+)] k7aRza7F7a 2 ??5?~rNBcs= ch# |Rh:K =gg (bd)pYx)PpdpdxQ Pp] i%NoNz$N;C sE 8-|| ek s )00gry d,dB9m4m ,L VP]c]V0P b,u3N s$E$ {# nf6 );]&Jo{Vy V!!aG&Gk &/ gbgZg($zvHMH(~(g[1q GT%ARTxH Xh wBB !7*, 3H?3:X W6+) QwHjb2o JC3l:VC#. {W +B11uK21sJ LBos?}oZ o:Q;= Erw 2oV`Yo% 9P9Se|f| _u T(s E42p9 ( s=:Y~{n|,Y YYM?\YYZ b[_`= O0U*e$jegk*k$ Q #!&DJ:JJJs]! lK C3i;jujxjov3 cwHwOtV*91: \H v2KAt#K` }Ewp (Y( no* PY Z~,7,Fx,?. z] DPZ8s5yR#öf otxGIe+I\J+G2YoGt ~c*]/ h?#LCeQS| @^NN^&R-Q AbeD_le pc dA/ 1#Xib [ Hqu9G}6#79 WbIxV S[`6b 83g7%0]%1r7r0 sS ^v+31^^^v# U/P A $u1$ry `hyyh#ZjI JR r o-cg! d7 s_3BX3k;|R LY5G@ )Y v?vkvtv^gidit Hk Gj /w 8=8 ^A meH ;pm=m61mn. z0 J@KAl; P:,, ~#mNGZm6 gE#jSk jM_ !mfg[ _:t@cC:I:tk Z@8 @to~Z K5W\o|Q\boWYWQy +hT#eV+ N%6 ]f@Z@$o@). %V 3}bbZ:}, [B-\ q)j/_oj@ u#xCV` & ?&w)fS&C 0C0kB8L8 F9 rpP sPx0UErP uEjw7 OK12)9@)PJ2J9 Ax :sX}g O[GHqqG0 UPj3 N0N -k#= PC, )Eb kL;:D&; A` w 0Lu(o w4 g,?DBsvjDvc_ T_4}T0B840 ln:C+ El +V+g+Y`r0MxMY tf wnw r^| p?s JD7T7,(7A.



Please login or register for full access


Already registered?  Login

Chat with BeiGene